health economics and outcomes research

Research in Review

ED Use, Hospitalizations High Among Patients With Parkinson‚Äôs Disease

04/12/2017

JCP Editors

Patients with Parkinson’s disease (PD) frequently utilize emergency department (ED) services and are frequently hospitalized, according to the results of a retrospective study. ----- Related Content Opicapone...

...

04/12/2017

Journal of Clinical Pathways

Research in Review

Daratumumab Cost-Effective for Refractory Multiple Myeloma

04/10/2017

JCP Editors

Single agent daratumumab may serve as a more cost-effective treatment strategy than pomalidomide for patients with refractory multiple myeloma. ----- Related Content Daratumumab improves progression-free survival...

Single...

04/10/2017

Journal of Clinical Pathways

Research in Review

Hypersensitivity Reactions Present Clinical, Economic Burden for Patients With NSCLC

03/24/2017

JCP Editors

Patients with non-small cell lung cancer (NSCLC) who develop hypersensitivity reactions to first-line chemotherapy are faced with increasing clinical burden and rising costs, according to research presented at the...

...

03/24/2017

Journal of Clinical Pathways

Research in Review

Consolidation Therapy With Chemo Improves Survival for Patients With CLL

03/06/2017

JCP Editors

An intravenous consolidation regimen developed for patients with chronic lymphocytic leukemia (CLL) was found to be safe and effective, according to a report in the European Journal of...

An...

03/06/2017

Journal of Clinical Pathways

Research in Review

12/29/2016

JCP Editors

A new study sheds light on factors that make it more likely patients with cancer will not adhere to their treatment because of cost reasons. ----- Related Content Cognitive Factors Linked to Treatment Adherence in...

A new...

12/29/2016

Journal of Clinical Pathways

Research in Review

Specialized Surveillance Cost-Effective, Not Linked to Overtreatment in High-Risk Melanoma Population

12/13/2016

JCP Editors

A specialized surveillance program designed to monitor individuals deemed at high risk for melanoma proved cost-effective and may reduce overtreatment rates compared with standard care, according to study results...

A...

12/13/2016

Journal of Clinical Pathways

Research in Review

Surveillance Superior to Standard Care for Melanoma

11/01/2016

JCP Editors

Specialized surveillance may be more cost effective and lead to fewer invasive procedures compared with standard care for patients with a high risk of melanoma, according to a study published in the Journal of...

...

11/01/2016

Journal of Clinical Pathways

Research in Review

Pembrolizumab More Cost Effective Than Docetaxel for PD-L1-Positive NSCLC

10/31/2016

JCP Editors

The associated improvement in survival and quality-adjusted life years (QALYs) makes pembrolizumab a more cost-effective option than docetaxel for patients with programmed death ligand 1 (PD-L1)-positive non-small...

The...

10/31/2016

Journal of Clinical Pathways

Research in Review

Study Identifies Steep Price Hikes for Older Cancer Drugs

10/17/2016

JCP Editors

The rising cost of cancer drugs continues to draw criticism from leading academic researchers, and threatens health care budgets. In a new study, researchers found that the price of older drugs increased more in a...

The...

10/17/2016

Journal of Clinical Pathways

Research in Review

Advertising Directly to Patients Dangerous, Suggests New Editorial

08/20/2016

JCP Editors

Cancer-related, direct-to-consumer advertising (CR-DTCA) has the potential to promote misconceptions about the efficacy and toxic effects of new therapeutics, which could be detrimental to patients and the...

...

08/20/2016

Journal of Clinical Pathways